Modified yeasts and uses thereof, in particular for producing steroid derivatives
AssigneeAventis Pharma S.A.
InventorsBruno Dumas, Gilles Cauet, Tilman Achstetter, Eric Degryse
Life of this patent
Estimating the term…
Loading patent…
AssigneeAventis Pharma S.A.
InventorsBruno Dumas, Gilles Cauet, Tilman Achstetter, Eric Degryse
Estimating the term…
The present invention relates to novel yeast strains, methods and genetic constructs for their preparation, and their use for the synthesis or modification of steroidal compounds. More particularly, the invention describes strains having a reduced 20αHSD type activity, in particular by modifying the GCY1 and/or YPR1 genes. The yeast strains of the invention make it possible to improve the efficiency of the synthesis or to increase the selectivity or the yields of the method, as well as the quality of the final product. The strains, methods and compounds of the invention are useful in the search for, the development and the production of products with therapeutic or prophylactic activity, in humans or animals, in particular of steroidal derivatives.
Method for modifying a steroid compound, comprising bringing this compound or a precursor thereof into contact with a yeast having a reduced 20αHSD activity, or a preparation derived from such a yeast.
Method for producing steroidal derivatives from hydroxysteroid compounds using a yeast having a reduced 20αHSD type activity, or a preparation derived from such a yeast.
Method for converting 17α-hydroxyprogesterone using a yeast having a reduced 20αHSD type activity, or a preparation derived from such a yeast.
Method according to any one of the preceding claims, characterized in that the yeast has one or more nonfunctional GCY1 and/or YPR1 genes.
Method according to any one of the preceding claims, characterized in that the yeast is a Saccharomyces yeast.
Method according to one of the preceding claims, characterized in that the nonfunctional gene(s) exhibit(s) a deletion and/or an insertion.
Yeast strain, characterized in that it possesses a genetic modification of the YPR1 and/or GCY1 gene(s).
Method of modifying the 20αHSD activity of a yeast, comprising modifying the activity of the GCY1 and/or YPR1 gene of the said yeast.
Use of a yeast having a reduced 20αHSD activity, or a preparation derived from such a yeast, for the preparation, production, synthesis, modification and/or improvement of steroidal compounds in vitro or ex vivo.
Use of a yeast having a reduced 20αHSD activity, or a preparation derived from such a yeast, for the conversion of 17α-hydroxyprogesterone to 11-deoxycortisol.
Dependencies are inferred from the claim text.